Specialized Transporter Services Optivia Biotechnology offers comprehensive transporter screening services and solutions for DDI, DMPK, safety, and pharmacology, positioning it as a key partner for biotech and pharmaceutical companies seeking advanced transporter research capabilities.

Recent Acquisition Boost Following its acquisition by BioIVT in 2018, Optivia has expanded its resources and integrated into a larger network, opening opportunities for cross-selling its assay services to a broader client base within BioIVT’s extensive portfolio.

Innovative Product Launch The launch of the TransFlex transporter assay system in 2016 demonstrates Optivia's focus on developing cutting-edge tools, offering potential sales avenues through marketing new, efficient solutions to organizations needing high-throughput transporter testing.

Market Positioning Operating within a small team of up to 10 employees and with revenues between one and ten million dollars, Optivia is positioned as a specialized CRO, which can be targeted for customized, high-value partnership opportunities in transporter research.

Technology Stack Usage Utilizing diverse digital tools like HubSpot and Mailchimp indicates an active digital engagement strategy, suggesting opportunities for targeted outreach and personalized sales efforts to biotech and pharma clients actively seeking transporter solutions.